Profile
Asst Prof Nicholas GLEADALL
Principal Investigator
Nick is an Assistant Professor in the Department of Haematology at the University of Cambridge. In 2020 he was awarded his PhD, having already introduced next-generation sequencing into routine NHS service use for improved pathogen detection and rare disease diagnosis. During his PhD, he developed a new array-based DNA test for comprehensive blood group, platelet (HPA) and tissue type (HLA) typing, and founded the Cambridge-led Blood transfusion Genomics Consortium, a global public–private partnership. He leads on computational and electronic health record aspects for the BloodCounts! consortium.
ng384@cam.ac.uk
Cambridge
Principal Investigators
BloodCounts!
Research Interest
Key Publications
Google Scholar Link
Mlcochova, Petra, et al. "SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion." Nature 599.7883 (2021): 114-119.
Kemp, Steven A., et al. "SARS-CoV-2 evolution during treatment of chronic infection." Nature 592.7853 (2021): 277-282.
Turro, Ernest, et al. "Whole-genome sequencing of patients with rare diseases in a national health system." Nature 583.7814 (2020): 96-102.
Gleadall, Nicholas S., et al. "Development and validation of a universal blood donor genotyping platform: a multinational prospective study." Blood Advances 4.15 (2020): 3495-3506.
Trompeter, S., et al. A National Programme of a High Throughput Axiom Array Genotyping Platform for HEA and HLA Testing for All Patients with Sickle Cell, Thalassaemia and Transfusion Dependent Rare Inherited Anaemias in the United Kingdom, Blood, 2024.